Study Shows That Injections Used For Weight Loss Can Lead To Losing Eyesight
A study links weight-loss injections like Ozempic to a higher risk of sudden vision loss from NAION, a rare eye condition, particularly in diabetic and overweight patients.
A later consideration joins medication utilized for weight misfortune and diabetes, to an expanded chance of NAION, an uncommon eye condition causing sudden vision misfortune.
The wellness industry offers different weight-loss arrangements, but these strategies can come with side impacts. A later thought distributed in JAMA Ophthalmology raises concerns, connecting certain well-known solutions for weight misfortune and diabetes to an expanded chance of non-arteritic front ischemic optic neuropathy (NAION).
NAION could be a sort of eye stroke causing sudden, effortless vision misfortune in one eye. They consider examined semaglutide drugs like Ozempic and Wegovy, which are utilized for both diabetes administration and weight misfortune.
The inquiry uncovered an altogether higher chance of NAION in patients taking semaglutide. People with diabetes on these medicines were four times more likely to create NAION compared to those on other medicines. For overweight or stout patients, the hazard is taken off to seven times higher with semaglutide utilized.
It's important to note that NAION could be an uncommon condition, influencing generally 10 out of each 100,000 individuals. In any case, the ponder including about 1,700 semaglutide clients (for sort 2 diabetes or weight) proposes a potential connection. Patients with diabetes taking semaglutide showed an 8.9% rate of NAION compared to as it were 1.8% with other medicines. So also, for weight treatment, semaglutide clients had a 6.7% rate, compared to a much lower 0.8% with elective drugs.
What's Your Reaction?
